Antiverse
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sbarc Spark Maindy Rd, Cardiff, South Gl...Website
www.antiverse.ioRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Antiverse
Antiverse is a tech-bio company developing the next-generation of computational antibody design technology to enable design for challenging drug targets, including G-protein coupled receptors and ion channels.Explore more
Antiverse Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Antiverse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Antiverse has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Antiverse launches new products
Funding: Get notified immidiatlly once Antiverse has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Antiverse is spiking on competitors!
Click to see if Antiverse had a recent Job posting/layoffs
Antiverse, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Antiverse
Earning: See what the market has to say on Antiverse recently announced quarterly report
Recommended Actions
Find VP level buyers at Antiverse
Find more new buyers
Compare Similar Companies to Antiverse
Compare insights from companies similar to Antiverse, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Antiverse is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Antiverse is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Antiverse.
Antiverse financials insights
Gather financial insights about Antiverse, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$2M
2023
Other Financing Round
$3M
2024
Angel/Seed
$4.6M
2026
Series A
$9.3M
Antiverse Tech Stack
A closer look at the technologies used by Antiverse
See more technologies
Most Recent Scoops
Open Position
Open Position
Funding
Funding
Funding
Funding
Funding
Antiverse News & Media
Investors back Antiverse to accelerate AI-driven drug discovery in $9.3 million round
Innovation Investment Capital Limited Partnership (IIC), the Cardiff Capital Region (CCR) backed fund, and the Development Bank of Wales today announced a joint equity investment in Antiverse Limited, the Cardiff-based artificial intelligence-driven TechBio company, alongsideAntiverse secures $9.3M Series A for AI antibody platform
UK-based Antiverse, abiotech company developing AI-designed therapeutic antibodies forhard-to-target disease targets, has closed a $9.3 million Series A round led bySoulmates Ventures, with participat...Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company designing antibodies for challenging targets, have today announced a multi-target partnership and licensing agreement to design antibodies for G-protein coupled receptors (GPCRs).Antiverse: £3.5 Million Raised For Advancing GenAI-Based Antibody Design Platform
Antiverse, a tech company that is designing antibodies for challenging targets, today announced it had added £3.5 million ($4.6 million) to its seed funding.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Antiverse
Sign Up For FreeTo access detailed company insights
Antiverse is a tech-bio company developing the next-generation of computational antibody design technology to enable design for challenging drug targets, including G-protein coupled receptors and ion channels.... Read More
